Success Metrics

Clinical Success Rate

100.0%

Based on 5 completed trials

Completion Rate

100%(5/5)

Active Trials

1(17%)

Results Posted

0%(0 trials)

Phase Distribution

Ph not_applicable

50%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution3 total trials

N/ANon-phased studies

3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(5)

Detailed Status

Completed5

Recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

completed583%

recruiting117%

Recent Activity

1 active trials

Showing 5 of 6

completednot_applicable

Clinical Trials (6)

Showing 6 of 6 trials

NCT04900090Not Applicable

Tahiti-families: Polynesian Families of Gout Patients

Completed

NCT04812886Not Applicable

Epidemiology of Gout in French Polynesia

Completed

NCT07343336

Landscape of Gout in French Polynesia.

Recruiting

NCT05607797Not Applicable

Genetic of Chronic Kidney Disease and Gout in New Caledonia

Completed

NCT05975502

Congenital Syphilis in Switzerland

Completed

NCT03614871

Snuff Use, Smoking, Periodontal Health and Premature Death: 30-year Study

Completed

All 6 trials loaded

Drug Details

Intervention Type: OTHER
Total Trials: 6